LEARN ABOUT THE LATEST IN PHARMACEUTICAL EDUCATION
Discover resources and valuable insights to stay informed and up-to-date in the constantly evolving world of the pharmaceutical industry.
Riverside Acceleration Capital Investment
We are excited to announce Riverside Acceleration Capital as a new investor. With their specialization in accelerating the growth of B2B software companies, we are confident about further scaling our solution for the global market. We look forward to collaborating with RAC to expand our solution and change the way people train in many more companies worldwide!
The Parenteral Drug Association (PDA) and Innerspace share the same mission of delivering high-quality and impactful education to the industry. In line with this goal, our Innerspace Virtual Reality Simulator and its built-in Frame-by-Frame Risk Profiling capabilities will become part of PDA training courses for professionals in the pharmaceutical and biopharmaceutical industries.
Develop Impactful Training in Times of the New Annex 1
The revised Annex 1 requires significant adjustments for manufacturers of sterile products, including the training cleanroom personnel. At the same time, advanced manufacturing procedures require highly qualified personnel. Join Sebastian Scheler, our Chief Methodologist at Innerspace, to learn about a practical guide on creating an impactful and Annex 1 compliant training curriculum as a crucial part of a Contamination Control Strategy.
Innerspace: Tyrolean VR Company Tripled Sales in 2022
Tyrolean startup Innerspace had a highly successful 2022, tripling sales to over four million euros. Their specialization in VR training for critical production environments, particularly in the pharmaceutical sector, contributed to their remarkable growth. Achieving a break-even point, Innerspace solidified their strong performance.
After securing a million-euro investment in 2020, Innerspace has announced an additional seven-figure investment. In its second round of financing, the company received a substantial euro investment from its existing investors, MAD Ventures and High-Tech Gründerfonds (HTGF), along with a new partner, aws Gründerfonds.